• Join Today!

Become a member and connect with:

  • An Active Online Community
  • Articles and Advice on SCD
  • Help Understanding Clinical Trials
reference materials

Secure-SCD Registry, Surveillance Epidemiology of Coronavirus (COVID-19) Under Research Exclusion

key information

source: Secure-SCD Registry

year: N/A

summary/abstract:

This registry is designed to capture pediatric and adult COVID-19 cases that are occurring across the world in patients living with sickle cell disease. The goal of the registry is to report on outcomes of cases of COVID-19 in this population of patients. We are asking providers caring for these patients to report all of their cases of COVID-19 to this registry. We expect the reporting of a case to take approximately 5-10 minutes.

With our sickle cell disease community worldwide, working collaboratively, we hope to quickly identify the impact of COVID-19 on patients with sickle cell disease and understand the impact of risk factors such as genotype, prior sickle cell disease complications, or sickle cell disease related medications, on health outcomes.

This is an international effort—we are counting on robust participation and collaboration. We will provide the sickle cell disease community with regularly updated summary information. The registry contains only de-identified data, in accordance with HIPAA Safe Harbor De-Identification standards.

read more

expertly curated content related to this topic

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close